1. Home
  2. ATYR vs NREF Comparison

ATYR vs NREF Comparison

Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.78

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$15.07

Market Cap

258.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
NREF
Founded
2005
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
258.6M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ATYR
NREF
Price
$0.78
$15.07
Analyst Decision
Buy
Hold
Analyst Count
6
3
Target Price
$8.75
$14.75
AVG Volume (30 Days)
2.6M
57.4K
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
13.35%
EPS Growth
N/A
132.43
EPS
N/A
3.08
Revenue
$190,000.00
$151,560,000.00
Revenue This Year
N/A
$23.96
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$4.87
Revenue Growth
N/A
107.15
52 Week Low
$0.64
$12.14
52 Week High
$7.29
$17.55

Technical Indicators

Market Signals
Indicator
ATYR
NREF
Relative Strength Index (RSI) 43.35 67.02
Support Level $0.70 $15.03
Resistance Level $0.83 $15.30
Average True Range (ATR) 0.06 0.25
MACD 0.03 0.07
Stochastic Oscillator 57.87 80.15

Price Performance

Historical Comparison
ATYR
NREF

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: